In their efforts to understand the beneficial effects of SAINT, an important new fast-acting brain stimulation treatment for refractory major...
Read More
On September 6, 2022, the U.S. Food and Drug Administration cleared the way for marketing of a rapid-acting brain-stimulation approach...
Read More
In its first randomized, placebo-controlled test, an enhanced form of non-invasive brain stimulation called SNT (Stanford Neuromodulation Therapy, formerly called...
Read More